Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “1- Women”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03463681
What this trial is testing

CaBozantinib in Patients With Advanced or Unresectable Renal cEll cArcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 49
Early research (Phase 1)Study completedNCT05547100
What this trial is testing

Study of the Breast Milk Pharmacokinetics of Olanzapine and Samidorphan

Who this might be right for
Focus of Study is on Healthy Lactating Women
Alkermes, Inc. 12
Not applicableLooking for participantsNCT07774000
What this trial is testing

Efficacy of Topical Niacinamide Riboside on the Signs of Facial Skin Aging

Who this might be right for
Skin Aging on FaceSkin Care DermocosmeticsSkin Care+1 more
ChromaDex, Inc. 140
Not applicableUnknownNCT01371695
What this trial is testing

Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer

Who this might be right for
Cervical CancerCervical Intraepithelial Neoplasia IICervical Intraepithelial Neoplasia III
Onconix, Inc 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390995
What this trial is testing

TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other Solid Tumors

Who this might be right for
Ovarian CancerSolid Tumors
Takeda 28
Testing effectiveness (Phase 2)Looking for participantsNCT06799637
What this trial is testing

Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments

Who this might be right for
Advanced Solid TumorsPancreatic CarcinomaOvarian Cancer+1 more
Evopoint Biosciences Inc. 350
Early research (Phase 1)Not Yet RecruitingNCT07729995
What this trial is testing

BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease

Who this might be right for
Rheumatoid Arthritis (RA)Systemic Lupus Erthematosus (SLE)Dermatomyositis (DM)+1 more
Luminary Therapeutics 94
Early research (Phase 1)Looking for participantsNCT07304128
What this trial is testing

PLB-002 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Primelink BioTherapeitics(ShenZhen) Limited 100
Post-approval studies (Phase 4)Study completedNCT02613039
What this trial is testing

Oral Contraceptive Therapy and Sexuality

Who this might be right for
Contraceptive UsageSexual BehaviorMental Health Wellness 1
University of Florence 10
Large-scale testing (Phase 3)Ended earlyNCT00742339
What this trial is testing

Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome

Who this might be right for
CirrhosisHepatorenal Syndrome
University of Padova 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT06399757
What this trial is testing

Investigate APL-5125 in Adults With Advanced Solid Tumors

Who this might be right for
Colorectal CancerCholangiocarcinomaAppendiceal Adenocarcinoma+6 more
Apollo Therapeutics Ltd 100
Testing effectiveness (Phase 2)Study completedNCT04704219
What this trial is testing

Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 160
Not applicableStudy completedNCT04175067
What this trial is testing

Evaluation of Thiol Disulfide Balance in Stage 1 Endometrium Cancer

Who this might be right for
Endometrium CancerOxidative Stress
Muğla Sıtkı Koçman University 117
Not applicableLooking for participantsNCT07743567
What this trial is testing

Gestational Response, Outcomes, and Weight After GLP-1 Use

Who this might be right for
Pregnant IndividualsObesity & OverweightGestational Weight Gain
University of Kansas Medical Center 400
Large-scale testing (Phase 3)Active Not RecruitingNCT04042402
What this trial is testing

Long Term Extension Study in Patients With Primary Hyperoxaluria

Who this might be right for
Primary Hyperoxaluria Type 1 (PH1)Primary Hyperoxaluria Type 2 (PH2)Kidney Diseases+3 more
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 75
Early research (Phase 1)UnknownNCT05843305
What this trial is testing

BPI-452080 in Subjects With Solid Tumors

Who this might be right for
Solid TumorRenal Cell CarcinomaVon Hippel-Lindau Disease
Betta Pharmaceuticals Co., Ltd. 87
Early research (Phase 1)Study completedNCT05760261
What this trial is testing

Drug Interaction Assessment of GSK3882347 in Healthy Participants Aged 18 to 65 Years

Who this might be right for
Urinary Tract Infections
GlaxoSmithKline 27
Early research (Phase 1)Study completedNCT00881062
What this trial is testing

Investigate Absorption, Metabolism and Excretion of [14C}-Proellex Following Single Oral Dose in Healthy Females

Who this might be right for
ABSORPTIONMETABOLISMEXCRETION
Repros Therapeutics Inc. 6
Early research (Phase 1)UnknownNCT04142931
What this trial is testing

Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

Who this might be right for
Stage IV Non-small Cell Lung CancerStage IV MelanomaTriple Negative Breast Cancer+1 more
Dr. Ronnie Shapira 30
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Next Page